Pioneering the past, present and future of research

Each year, Baylor Scott & White Health dedicates a week-long observance to celebrate our long-standing role as a leader in research and our ongoing efforts to continually improve patient care. This year, for the fifth annual Research Week at Baylor Scott & White, we’re honoring the Pioneers of the Past, Present and Future. From detecting … Continue reading Pioneering the past, present and future of research

From the Mother: “We consider ourselves profoundly blessed to have been a part of this study”

On Friday, Baylor University Medical Center at Dallas announced that a baby had been born to a mother who received a uterus transplant as part of a landmark clinical trial conducted over the past year and a half. The patient and her family have asked for privacy at this time, but they did want to … Continue reading From the Mother: “We consider ourselves profoundly blessed to have been a part of this study”

An aspirin a day: Clinical trial aims to find cheaper ways to research medicine

For four decades, people have been taking aspirin to ward off strokes and heart attacks. But is the commonly used “baby aspirin” dose of 81 milligrams better, or the regular dose of 325 milligrams? To help settle the issue, an unusual clinical trial is underway at Baylor Heart and Vascular Institute at Baylor University Medical Center … Continue reading An aspirin a day: Clinical trial aims to find cheaper ways to research medicine

Baylor University Medical Center to offer uterus transplants in clinical trial

They say motherhood is a gift. It’s that surreal and unforgettable moment of holding your newborn in your arms for the first time, gazing into a tiny face you feel like you’ve known your whole life. But for some, life throws a curve ball, extinguishing high hopes of motherhood for many women diagnosed with infertility. … Continue reading Baylor University Medical Center to offer uterus transplants in clinical trial

4 Things to Know About The New Breast Cancer “Smart Bomb”

The experimental drug, T-DM1, also known as the breast cancer “smart bomb,” is a phrase that’s been on everyone’s lips and search engines since Monday when it was announced as the “miracle drug” breast cancer treatment. Kimberly Blackwell, M.D., an oncologist at Duke University Medical Center and lead investigator of the T-DM1 study, presented her … Continue reading 4 Things to Know About The New Breast Cancer “Smart Bomb”